Skip to content

Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?

Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06308965
Acronym
USP
Enrollment
300
Registered
2024-03-13
Start date
2024-06-11
Completion date
2027-03-31
Last updated
2024-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty Complications, Tensor Fasciae Latae Syndrome

Keywords

Total Hip Arthroplasty, Ultra Sparing Procedure, Direct Anterior Approach

Brief summary

During direct anterior approach (DAA) for total hip arthroplasty (THA), ligation of the lateral femoral circumflex artery and vessel is always conducted. However, this standardized procedure may jeopardize blood muscle perfusion and cause tenderness in the tensor fascia lata muscle. The investigators want to investigate whether blood vessel-sparing surgery is feasible, reproducible, and would alter outcomes following DAA THA. The surgical technique of the vessel-sparing procedure will be described and investigated in a prospective blinded RCT. The investigators hypothesize that the vessel-sparing technique is feasible in 60% of the patients. If these vessels were not sacrificed, the investigators expect the incidence of TFL tendinopathy to be lower.

Detailed description

Primary objective: to compare a group with successful vessel-sparing with a vessel-sacrificed-group for: 1. Incidence of TFL tendinopathy 2. Patient-reported outcomes 3. Component placement Secondary objective: to observe the feasibility of the vessel-sparing surgical technique. This is a monocentric prospective randomized blinded clinical trial during a period of minimum 3 years or until 150% of the sample size is included (100 patients).

Interventions

PROCEDUREVessel ligation technique

Vessel ligation

PROCEDUREVessel sparing technique

Vessel sparing

Sponsors

Ziekenhuis Oost-Limburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

Participants will be blinded and randomized into two cohorts. The selection and randomization protocol is as follows: participants eligible for the study are requested to participate and informed by the study nurse. If the patient agreed to participate, informed consent is obtained, and the patient is included in the study. At that time, the study nurse uses a mobile randomization application (Random, Dublin, Ireland) to allocate them either to the 'standard' (sacrificing the vessels) or 'vessel sparing' DAA. Weighted randomization (1:2) is applied to compensate for a dropout of patients planned for vessel sparing surgery, but in whom the vessels were damaged unintendedly. In case a bilateral procedure will be performed, each side is randomized individually. Surgery will be performed by the surgeon. Data collection before and after surgery is collected by personal assistant who is unaware of group assignment.

Intervention model description

This is a monocentric prospective randomized blinded clinical trial during a period of minimal 3 years or until 150% of sample size is included (100 patients).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

To be eligible to participate in this study, a subject must meet all criteria below; * Scheduled for THA by Dr. Frans-Jozef Vandeputte or Professor Dr. Kristoff Corten * Provide signed and dated informed consent * Males or females age \> 18 years

Exclusion criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study: * Neurological problems with sensorial and/or motoric disturbances (Multiple Sclerosis, Parkinson's disease, hemiplegia, …) * Previous surgery of the ipsilateral hip * Ipsilateral neck of femur fracture * Previous contralateral THA * Significant hip deformity: Crowe type 3 and 4 dysplasia, Leg-Calvé-Perthes * Avascular necrosis of the femoral head * Participating in another study that may interfere with participation in this study

Design outcomes

Primary

MeasureTime frameDescription
b-2) Patient-reported outcome 2: Hip And Groin Outcome Score (HAGOS)one year follow-upHip And Groin Outcome Score (HAGOS) minimum (worse) score = 0 maximum (best) score = 100
a) Incidence of TFL tendinopathyone year follow-upClinical examination to detect TFL tendinopathy
b-1) Patient-reported outcome 1: modified Harris Hip Score (HHS)one year follow-upmodified Harris Hip Score (HHS) minimum (worse) score = 0 maximum (best) score = 44
c) Component placement (x-rays)one year follow-upUsing pelvic anteroposterior radiographs, with both legs internally rotated 15°: Acetabular version (Lewinnek method). Acetabular inclination Femoral alignment Under-sizing in case the femoral component is not touching cortical bone.
b-3) Patient-reported outcome 3: Forgotten Joint Scoreone year follow-upForgotten Joint Score minimum (worse) score = 0 maximum (best) score = 100
b-4) Patient-reported outcome 4: Hip disability and Osteoarthritis Outcome Score (HOOS).one year follow-upHip disability and Osteoarthritis Outcome Score (HOOS) minimum (worse) score = 0 maximum (best) score = 100

Secondary

MeasureTime frameDescription
Vessel sparing succesfullend of surgerySuccessful Yes/No

Countries

Belgium

Contacts

Primary ContactFrans-Jozef Vandeputte, MD
Frans-Jozef.Vandeputte@zol.be+32 89 32 61 29

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026